Prepared for Ross O. | Delivered November 29, 2019
Sustainability Pharmaceutical Companies.
Review your project details
To obtain an in-depth understanding of the sustainability initiatives adopted by major pharmaceutical companies covering all sustainability issues, targets, timeline, and frameworks.
Sustainability Issues Identified
pursues sustainability in
access to healthcare,
ethics and transparency.
SDG Goals Alignment and Progress
The firm also measures its success using the Sustainable Development Goals (
). Out of the 17 major areas identified by the UN, AstraZeneca aligns itself to
and routinely reports its progress in those areas.
Good Health and Well-Being
AstraZeneca hopes to achieve the following
reduce premature mortality from non-communicable diseases,
strengthen the prevention and treatment of substance abuse,
reduce the number of global deaths and accidents from road traffic accidents,
achieve universal health coverage, and
increase the health workforce in developing countries.
In achieving the above goals, the company has performed the following
people through various access to healthcare programs and initiatives such as the Healthy Heart Africa as well as the Healthy Lung and
youths through the Young Health Program,
healthcare workers, and
partnered with over
The firm hopes to foster
women’s full and effective participation
and provide equal opportunities for leadership at all levels of decision-making in political, economic and public life.
In achieving the above goal, the company has performed the following activities:
of its senior management staff are women (up from 44.4% in 2017),
of its executive staff are women (up from 28.1% in 2017), and
of its Board of Directors are women (same as 2017 figures).
The firm has also made significant progress with Sustainable Development Goals
Science Based Targets
AstraZeneca signed up on Science Based Targets about three years ago in the month of October2016. According to its target profile, the company committed itself to reducing scope 1 emissions by
and scope 2 emissions
from 2015 to 2025. Also, the company plans to reduce all scope 3 emissions by
per million USD of sales within the same time frame.
AstraZeneca's environmental management
are based on frameworks provided by the International Organization for Standardization (ISO).
It also created the
Sustainability Partner Guide and Framework
to set clear expectations for its direct suppliers to ensure their values are consistent with its own.
Chief Sustainability Officer
is the Sustainability and Chief Compliance Officer at AstraZeneca.